A Study to Assess the Safety and the Efficacy of the Combination of TH-302 and Sunitinib in Neuroendocrine Pancreatic Tumours
Clinical trial NCT02402062 · COMPLETED
Trial details
- NCT number
- NCT02402062
- Sponsor
- Grupo Espanol de Tumores Neuroendocrinos
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-11
- Primary completion
- 2018-05-31
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.